Literature DB >> 8086034

Colony stimulating factor-1 expression in human glioma.

R L Alterman1, E R Stanley.   

Abstract

Colony stimulating factor 1 (CSF-1) is a functionally versatile, circulating homodimeric growth factor that stimulates the survival, proliferation, and differentiation of mononuclear phagocytic cells, the differentiation of osteoclast progenitor cells and that regulates cells of the female reproductive tract. CSF-1 is also expressed in the central nervous system where it may regulate the differentiation and activation of microglia. The diverse forms of CSF-1 are all encoded by a single gene. Alternative posttranscriptional splicing and posttranslational cleavage determines whether CSF-1 will be produced as a secreted proteoglycan, secreted glycoprotein, or as a cell-surface glycoprotein that may be involved in cell-cell interactions. CSF-1 is expressed in glioblastoma cell-lines, normal human astrocytes, and in operative specimens of human glioma. The CSF-1 receptor, encoded by the c-fms proto-oncogene, is also expressed in human gliomas. We conclude that coexpression of CSF-1 and its receptor in some human gliomas hints at a possible autocrine or paracrine growth stimulatory role for CSF-1; however, its function in the mammalian CNS remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086034     DOI: 10.1007/BF02815350

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  23 in total

1.  CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.

Authors:  Kien Pham; Defang Luo; Che Liu; Jeffrey K Harrison
Journal:  J Neuroimmunol       Date:  2012-03-16       Impact factor: 3.478

Review 2.  Immunosuppressive mechanisms in glioblastoma.

Authors:  Edjah K Nduom; Michael Weller; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

3.  Microglia/macrophages promote glioma progression.

Authors:  Haiyan Zhai; Frank L Heppner; Stella E Tsirka
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

4.  Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.

Authors:  Rui Pedro Galvão; Hui Zong
Journal:  Curr Pathobiol Rep       Date:  2013-03-01

5.  A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells.

Authors:  Marco Magistri; Nathalie Khoury; Emilia Maria Cristina Mazza; Dmitry Velmeshev; Jae K Lee; Silvio Bicciato; Pantelis Tsoulfas; Mohammad Ali Faghihi
Journal:  Eur J Neurosci       Date:  2016-09-25       Impact factor: 3.386

Review 6.  The role of microglia in central nervous system immunity and glioma immunology.

Authors:  Isaac Yang; Seunggu J Han; Gurvinder Kaur; Courtney Crane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-11-18       Impact factor: 1.961

Review 7.  The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions.

Authors:  Kelly Mitchell; Katie Troike; Daniel J Silver; Justin D Lathia
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

8.  Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.

Authors:  Mamatha Bangalore Nijaguna; Vikas Patil; Serge Urbach; Shivayogi D Shwetha; Kotha Sravani; Alangar S Hegde; Bangalore A Chandramouli; Arimappamagan Arivazhagan; Philippe Marin; Vani Santosh; Kumaravel Somasundaram
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

Review 9.  The molecular profile of microglia under the influence of glioma.

Authors:  Wei Li; Manuel B Graeber
Journal:  Neuro Oncol       Date:  2012-05-09       Impact factor: 12.300

10.  Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme.

Authors:  Nicolai El Hindy; Kathy Keyvani; Axel Pagenstecher; Philip Dammann; I Erol Sandalcioglu; Ulrich Sure; Yuan Zhu
Journal:  Neuro Oncol       Date:  2013-06-20       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.